Literature DB >> 12874196

Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2.

André Báfica1, Charles A Scanga, Marco L Schito, Sara Hieny, Alan Sher.   

Abstract

Mycobacterial infection has been implicated as a possible factor in AIDS progression in populations where HIV-1 and Mycobacterium tuberculosis are coendemic. In support of this concept, we have previously shown that HIV-1-transgenic (Tg) mice infected with mycobacteria display enhanced viral gene and protein expression. In this study, we demonstrate that the induction of HIV-1 observed in this model is dependent on Toll-like receptor 2 (TLR2), a pattern recognition receptor known to be involved in mycobacteria-host interaction. Spleen cells from HIV-1-Tg mice deficient in TLR2 (Tg/TLR2(-/-)) were found to be completely defective in p24 production induced in response to live M. tuberculosis or Mycobacterium avium as well as certain mycobacterial products. Importantly, following in vivo mycobacterial infection, Tg/TLR2(-/-) mice failed to display the enhanced HIV-1 gag/env mRNA and p24 protein synthesis exhibited by wild-type Tg animals. Together, these results argue that TLR2 plays a crucial role in the activation of HIV-1 expression by mycobacterial coinfections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874196     DOI: 10.4049/jimmunol.171.3.1123

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias.

Authors:  Mihai G Netea; Jos W M Van der Meer; Roger P Sutmuller; Gosse J Adema; Bart-Jan Kullberg
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

2.  CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate.

Authors:  Jinglin Sun; Timothy Soos; Vineet N Kewalramani; Kristin Osiecki; Jian Hua Zheng; Laurie Falkin; Laura Santambrogio; Dan R Littman; Harris Goldstein
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Proline-proline-glutamic acid (PPE) protein Rv1168c of Mycobacterium tuberculosis augments transcription from HIV-1 long terminal repeat promoter.

Authors:  Khalid Hussain Bhat; Chinta Krishna Chaitanya; Nazia Parveen; Raja Varman; Sudip Ghosh; Sangita Mukhopadhyay
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

4.  Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation.

Authors:  Jian Ding; Aprille Rapista; Natalia Teleshova; Goar Mosoyan; Gary A Jarvis; Mary E Klotman; Theresa L Chang
Journal:  J Immunol       Date:  2010-02-10       Impact factor: 5.422

5.  Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.

Authors:  Amanda B Macedo; Rachel S Resop; Laura J Martins; Matthew A Szaniawski; Eric S Sorensen; Adam M Spivak; Douglas F Nixon; R Brad Jones; Vicente Planelles; Alberto Bosque
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-10       Impact factor: 2.205

6.  HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.

Authors:  Octavio A González; Mengtao Li; Jeffrey L Ebersole; Chifu B Huang
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

Review 7.  Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapy.

Authors:  Chris L McGowin; Richard B Pyles
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

8.  GeneChip analyses of global transcriptional responses of murine macrophages to the lethal toxin of Bacillus anthracis.

Authors:  Jason E Comer; Cristi L Galindo; Ashok K Chopra; Johnny W Peterson
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

9.  Dual TLR2 and TLR7 agonists as HIV latency-reversing agents.

Authors:  Amanda B Macedo; Camille L Novis; Caroline M De Assis; Eric S Sorensen; Paula Moszczynski; Szu-Han Huang; Yanqin Ren; Adam M Spivak; R Brad Jones; Vicente Planelles; Alberto Bosque
Journal:  JCI Insight       Date:  2018-10-04

10.  Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.

Authors:  L Heggelund; J K Damås; A Yndestad; A M Holm; F Mūller; E Lien; T Espevik; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.